Focal cortical dysplasia type II (malformations of cortical development) aberrantly expresses apoptotic proteins

Applied Immunohistochemistry and Molecular Morphology

Volumn 16, Issue 5, 2008, Pages 471-476

  Chamberlain, Wendy A ^a   Prayson, Richard A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; bax; bcl 2; bcl XL; Cortical dysplasia; Malformations of cortical development; p53

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; APOPTOSIS REGULATORY PROTEIN; BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; PROTEIN BCL X;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; BRAIN NERVE CELL; CHILD; CLINICAL ARTICLE; CORTICAL DYSPLASIA; FEMALE; GLIOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MEDICAL RECORD REVIEW; NEUROEPITHELIOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SCHOOL CHILD; STAINING; TERATOMA; BIOSYNTHESIS; CHEMISTRY; CLASSIFICATION; COMPARATIVE STUDY; EPILEPSY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NERVOUS SYSTEM TUMOR; PATHOLOGY; PHYSIOLOGY;

ADOLESCENT; ADULT; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; GANGLIOGLIOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; MIDDLE AGED; NERVOUS SYSTEM NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 55949108816     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31815d9ac7     Document Type: Article

References (51)

1. Bast T, Ramantani G, Seitz A, et al. Focal cortical dysplasia: prevalence, clinical presentation and epilepsy in children and adults. Acta Neurol Scand. 2006;1132:72-81.
2. Luders H, Schuele SU. Epilepsy surgery in patients with malformations of cortical development. Curr Opin Neurol. 2006;192:169-174.
3. Crino PB, Miyata H, Vinters HV. Neurodevelopmental disorders as a cause of seizures: neuropathologic, genetic, and mechanistic considerations. Brain Pathol. 2002;122:212-233. (Pubitemid 34259924)
4. Foldvary-Schaefer N, Bautista J, Andermann F, et al. Focal malformations of cortical development. Neurology. 2004;626(Suppl 3):S14-S19.
5. Sarkar C, Sharma MC, Deb P, et al. Neuropathological spectrum of lesions associated with intractable epilepsies: a 10-year experience with a series of 153 resections. Neurol India. 2006;542:144-150. Discussion 150-151. (Pubitemid 44015011)
6. Alexandre V Jr, Walz R, Bianchin MM, et al. Seizure outcome after surgery for epilepsy due to focal cortical dysplastic lesions. Seizure. 2006;156:420-427. (Pubitemid 44191870)
7. Siegel AM, Cascino GD, Meyer FB, et al. Surgical outcome and predictive factors in adult patients with intractable epilepsy and focal cortical dysplasia. Acta Neurol Scand. 2006;1132:65-71.
8. Fauser S, Schulze-Bonhage A. Epileptogenicity of cortical dysplasia in temporal lobe dual pathology: an electrophysiological study with invasive recordings. Brain. 2006;129(Pt 1):82-95. (Pubitemid 43063761)
9. Hudgins RJ, Flamini JR, Palasis S, et al. Surgical treatment of epilepsy in children caused by focal cortical dysplasia. Pediatr Neurosurg. 2005;412:70-76. (Pubitemid 40976758)
10. Bingaman WE. Surgery for focal cortical dysplasia. Neurology. 2004;626(Suppl 3):S30-S34.
11. Wang VY, Chang EF, Barbaro NM. Focal cortical dysplasia: a review of pathological features, genetics, and surgical outcome. Neurosurg Focus. 2006;201:E7.
12. Yamanouchi H, Jay V, Otsubo H, et al. Early forms of microtubuleassociated protein are strongly expressed in cortical dysplasia. Acta Neuropathol. 1998;955:466-470.
13. Crino PB, Trojanowski JQ, Eberwine J. Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity. Acta Neuropathol. 1997;93:619-627.
14. Fauser S, Becker A, Schulze-Bonhage A, et al. CD34-immunoreactive balloon cells in cortical malformations. Acta Neuropathol. 2004;1084:272-278. (Pubitemid 39317694)
15. Dubeau F, Tampieri D, Lee N, et al. Periventricular and subcortical nodular heterotopia. A study of 33 patients. Brain. 1995;118(Pt 5): 1273-1287.
16. Englund C, Folkerth RD, Born D, et al. Aberrant neuronal-glial differentiation in Taylor-type focal cortical dysplasia (type IIA/B). Acta Neuropathol. 2005;1095:519-533. (Pubitemid 40909197)
17. Vinters HV, Fisher RS, Cornford ME, et al. Morphological substrates of infantile spasms: studies based on surgically resected cerebral tissue. Childs Nerv Syst. 1992;81:8-17.
18. Duong T, De Rosa MJ, Poukens V, et al. Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia. Acta Neuropathol. 1994;875:493-503. (Pubitemid 24128977)
19. Prayson RA. Bcl-2 and Bcl-X expression in gangliogliomas. Hum Pathol. 1999;306:701-705.
20. Frater JL, Prayson RA, Morris III HH, et al. Surgical pathology findings of extratemporal-based intractable epilepsy. Arch Pathol Lab Med. 2000;124:545-549.
21. Taylor DC, Falconer MA, Bruton CJ, et al. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry. 1971; 344:369-387.
22. Goldblum JR, Shannon R, Kaldjian EP, et al. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms. Mod Pathol. 1993;66:663-668. (Pubitemid 2014262)
23. Tubbs RR, Sheibani K. Immunohistology of lymphoproliferative disorders. Semin Diagn Pathol. 1984;14:272-284.
24. Lo AC, Houenou LJ, Oppenheim RW. Apoptosis in the nervous system: morphological features, methods, pathology, and prevention. Arch Histol Cytol. 1995;582:139-149.
25. Leist M, Nicotera P. Apoptosis, excitotoxicity, and neuropathology. Exp Cell Res. 1998;2392:183-201.
26. Lindsten T, Ross AJ, King A, et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell. 2000;66: 1389-1399. (Pubitemid 32045931)
27. Roth W, Grimmel C, Rieger L, et al. Bag-1 and Bcl-2 gene transfer in malignant glioma: modulation of cell cycle regulation and apoptosis. Brain Pathol. 2000;102:223-234. (Pubitemid 30181091)
28. Vekrellis K, McCarthy MJ,Watson A, et al. Bax promotes neuronal cell death and is downregulated during the development of the nervous system. Development. 1997;1246:1239-1249. (Pubitemid 27142077)
29. Lewis J, Wesselingh SL, Griffin DE, et al. Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J Virol. 1996;703:1828-1835. (Pubitemid 26062946)
30. Farlie PG, Dringen R, Rees SM, et al. bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc Natl Acad Sci USA. 1995;9210:4397-4401.
31. Martinou JC, Dubois-Dauphin M, Staple JK, et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 1994;134: 1017-1030. (Pubitemid 24347313)
32. Zhong LT, Sarafian T, Kane DJ, et al. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA. 1993;9010:4533-4537. (Pubitemid 23148939)
33. Li H, Zhu H, Xu CJ, et al. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998;944:491-501. (Pubitemid 28391865)
34. Luo X, Budihardjo I, Zou H, et al. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998;944:481-490. (Pubitemid 28391864)
35. Pozniak CD, Radinovic S, Yang A, et al. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science. 2000;289:304-306.
36. Degenhardt K, Chen G, Lindsten T, et al. BAX and BAK mediate p53-independent suppression of tumorigenesis. Cancer Cell. 2002;23: 193-203. (Pubitemid 41043975)
37. White FA, Keller-Peck CR, Knudson CM, et al. Widespread elimination of naturally occurring neuronal death in Bax-deficient mice. J Neurosci. 1998;184:1428-1439.
38. Lindsten T, Golden JA, Zong WX, et al. The proapoptotic activities of Bax and Bak limit the size of the neural stem cell pool. J Neurosci. 2003;2335:11112-11119. (Pubitemid 37548946)
39. Yachnis AT. Neuropathology of pediatric brain tumors. Semin Pediatr Neurol. 1997;44:282-291.
40. Kaufmann T, Schlipf S, Sanz J, et al. Characterization of the signal that directs Bcl-xL, but not Bcl-2, to the mitochondrial outer membrane. J Cell Biol. 2003;1601:53-64. (Pubitemid 36091716)
41. Borner C. The Bcl-2 protein family: sensors and checkpoints for lifeor- death decisions. Mol Immunol. 2003;3911:615-647. (Pubitemid 35454076)
42. Parsadanian AS, Cheng Y, Keller-Peck CR, et al. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons. J Neurosci. 1998;183:1009-1019. (Pubitemid 28112923)
43. Patterson SD, Spahr CS, Daugas E, et al. Mass spectrometric identification of proteins released from mitochondria undergoing permeability transition. Cell Death Differ. 2000;72:137-144. (Pubitemid 30150781)
44. Otsuki Y. Various methods of apoptosis detection. Acta Histochem Cytochem. 2000;334:235-241.
45. Motoyama N, Wang F, Roth KA, et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science. 1995;267:1506-1510.
46. Krajewska M, Mai JK, Zapata JM, et al. Dynamics of expression of apoptosis-regulatory proteins Bid, Bcl-2, Bcl-X, Bax and Bak during development of murine nervous system. Cell Death Differ. 2002;92: 145-157. (Pubitemid 34144774)
47. Prayson RA. Bcl-2, bcl-x, and bax expression in dysembryoplastic neuroepithelial tumors. Clin Neuropathol. 2000;192:57-62.
48. Cepeda C, Andre VM, Vinters HV, et al. Are cytomegalic neurons and balloon cells generators of epileptic activity in pediatric cortical dysplasia? Epilepsia. 2005;46(Suppl):582-588.
49. Kim SK, Wang KC, Hong SJ, et al. Gene expression profile analyses of cortical dysplasia by cDNA arrays. Epilepsy Res. 2003;562-3: 175-183. (Pubitemid 37464930)
50. Blumcke I, Lobach M, Wolf HK, et al. Evidence for developmental precursor lesions in epilepsy-associated glioneuronal tumors. Micros Res Tech. 1999;461:53-58. (Pubitemid 29319278)
51. Gyure KA, Sandberg GD, Prayson RA, et al. Dysembryoplastic neuroepithelial tumor: an immunohistochemical study with myelin oligodendrocyte glycoprotein. Arch Pathol Lab Med. 2000;1241: 123-126.